Randomized_controlled_trial#:~:textual content=A%20randomized%20managed%20trial%20(or,groupspercent2C%20treating%20them%20in another waypercent2C%20and……

Sarris et al. Medicinal cannabis for psychiatric problems: a clinically-focused systematic assessment BMC Psychiatry (2020) 20:24…

Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, et al. Cannabidiol reduces the nervousness induced by simulated public talking in treatment-naive social phobia sufferers. Neuropsychopharmacology. 2011;36(6):1219–26.

Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, MartinSantos R, et al. Neural foundation of anxiolytic results of cannabidiol (CBD) in generalized social nervousness dysfunction: a preliminary report. J Psychopharmacol (Oxford, UK). 2011;25(1):121–30

Elms L, Shannon S, Hughes S, Lewis N. Cannabidiol in the treatment of post-traumatic stress dysfunction: a case sequence. J Altern Complement Med. 2019;25(4):392–7

Greer GR, Grob CS, Halberstadt AL. PTSD symptom reviews of sufferers evaluated for the New Mexico Medical cannabis Program. J Psychoactive Drugs. 2014;46(1):73–7.

Portenoy RK, Ganae-Motan ED, Allende S, Yanagihara R, Shaiova L, Weinstein S, et al. Nabiximols for opioid-treated most cancers sufferers with poorly managed persistent ache: a randomized, placebo-controlled, graded-dose trial. J Pain. 2012;13(5):438–49.

Shannon S, Opila-Lehman J. Effectiveness of cannabidiol oil for pediatric nervousness and insomnia as a part of posttraumatic stress dysfunction: a case report. Perm J. 2016;20(4):108–11.

Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in nervousness and sleep: a giant case sequence. Perm J. 2019;23:18–041.

Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. An open-label extension examine to research the long-term security and tolerability of THC/ CBD oromucosal spray and oromucosal THC spray in sufferers with terminal cancer-related ache refractory to robust opioid analgesics. J Pain Symptom Manag. 2013;46(2):207–18

ACTRN12618000078257. A examine to guage the efficacy of sublingual cannabinoid based mostly drugs extract in contrast with placebo for the treatment of Insomnia.

Zuardi A, Crippa J, Dursun S, Morais S, Vilela J, Sanches R, et al. Cannabidiol was ineffective for manic episode of bipolar affective dysfunction. J Psychopharmacol. 2010;24:135 –7.

Mitchell JT, Sweitzer MM, Tunno AM, Kollins SH, McClernon FJ. “I use weed for my ADHD ”: a qualitative evaluation of on-line discussion board discussions on cannabis use and ADHD. PloS one. 2016;11(5):e0156614.

Marijuana and Medicine: The Need for a Science-Based Approach: Hearing earlier than the Subcommittee on Criminal Justice, Drug Policy and Human

n Resources, U.S. House of Representatives, Second Sess. (April 1, 2004).

Cooper RE, Williams E, Seegobin S, Tye C, Kuntsi J, Asherson P. Cannabinoids in attention-deficit/hyperactivity dysfunction: a randomised managed trial. Eur Neuropsychopharmacol. 2017;27(8):795–808.

Source link